Literature DB >> 22617320

Europium-doped gadolinium sulfide nanoparticles as a dual-mode imaging agent for T1-weighted MR and photoluminescence imaging.

Jongjin Jung1, Mi Ae Kim, Jee-Hyun Cho, Seung Jae Lee, Ilseung Yang, Janggeun Cho, Seong Keun Kim, Chulhyun Lee, Joung Kyu Park.   

Abstract

We present a facile synthesis of europium-doped gadolinium sulfide (GdS:Eu(3+)) opto-magnetic nanoparticles (NPs) via sonochemistry. Their photoluminescence and strong paramagnetic properties enable these NPs to be utilized as an in vitro cell imaging and in vivo T(1)-weighted MR imaging probe. The GdS:Eu(3+) NPs have a prominent longitudinal (r(1)) relaxivity value, which is a critical parameter for T(1)-weighted MR imaging. Here, we showed not only their strong positive contrast effect to blood vessels and organs of mice, but also blood half-life and biodistribution including clearance from organs, in order to assess the GdS:Eu(3+) NPs as a competent nanocrystal-based T(1) contrast agent. We further showed confocal images of breast cancer cells containing GdS:Eu(3+) NPs to evaluate as a photoluminescence probe. Dual-mode imaging capability obtained from the GdS:Eu(3+) NPs will allow target-oriented cellular imaging as well as the resulting disease-specific MR imaging.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22617320     DOI: 10.1016/j.biomaterials.2012.04.059

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

1.  Physical justification for negative remanent magnetization in homogeneous nanoparticles.

Authors:  Shuo Gu; Weidong He; Ming Zhang; Taisen Zhuang; Yi Jin; Hatem ElBidweihy; Yiwu Mao; James H Dickerson; Michael J Wagner; Edward Della Torre; Lawrence H Bennett
Journal:  Sci Rep       Date:  2014-09-03       Impact factor: 4.379

2.  High performance magneto-fluorescent nanoparticles assembled from terbium and gadolinium 1,3-diketones.

Authors:  Rustem Zairov; Asiya Mustafina; Nataliya Shamsutdinova; Irek Nizameev; Beatriz Moreira; Svetlana Sudakova; Sergey Podyachev; Alfia Fattakhova; Gulnara Safina; Ingemar Lundstrom; Aidar Gubaidullin; Alberto Vomiero
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

3.  Ultra-wide range field-dependent measurements of the relaxivity of Gd1-xEuxVO4 nanoparticle contrast agents using a mechanical sample-shuttling relaxometer.

Authors:  Ching-Yu Chou; Mouna Abdesselem; Cedric Bouzigues; Minglee Chu; Angelo Guiga; Tai-Huang Huang; Fabien Ferrage; Thierry Gacoin; Antigoni Alexandrou; Dimitris Sakellariou
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

Review 4.  The Local Atomic Structure of Colloidal Superparamagnetic Iron Oxide Nanoparticles for Theranostics in Oncology.

Authors:  Elena Kuchma; Stanislav Kubrin; Alexander Soldatov
Journal:  Biomedicines       Date:  2018-07-18

Review 5.  Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance.

Authors:  Md Mominur Rhaman; Md Rezaul Islam; Shopnil Akash; Mobasharah Mim; Md Noor Alam; Eugenie Nepovimova; Martin Valis; Kamil Kuca; Rohit Sharma
Journal:  Front Cell Dev Biol       Date:  2022-09-02

Review 6.  Nanoparticle-based systems for T(1)-weighted magnetic resonance imaging contrast agents.

Authors:  Derong Zhu; Fuyao Liu; Lina Ma; Dianjun Liu; Zhenxin Wang
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

Review 7.  Modern micro and nanoparticle-based imaging techniques.

Authors:  Marketa Ryvolova; Jana Chomoucka; Jana Drbohlavova; Pavel Kopel; Petr Babula; David Hynek; Vojtech Adam; Tomas Eckschlager; Jaromir Hubalek; Marie Stiborova; Jozef Kaiser; Rene Kizek
Journal:  Sensors (Basel)       Date:  2012-11-02       Impact factor: 3.576

8.  Size-dependent MRI relaxivity and dual imaging with Eu0.2Gd0.8PO4·H2O nanoparticles.

Authors:  Yichen Li; Tao Chen; Weihong Tan; Daniel R Talham
Journal:  Langmuir       Date:  2014-05-13       Impact factor: 3.882

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.